Retraction
IFN-γ induces PD-L1 through p38/JNK/ERK signaling pathways and counteracts the tumor promoting effect mediated by PD-L1 in Glioblastoma
Paper Information
Record ID:
60657
Author(s):
Journal:
Publication Date:
June 29, 2022
Retraction Date:
November 29, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (7)
7
Total Citations1
Post-Retraction(14.3%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
372
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma
Xiaoya He, Hao Deng, Wei Liu et al. (5 authors)
Current Treatment Options in Oncology
Published: Dec 2024
2 citations
2 citations
372 days after retraction
Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis
Zixiao Wang, Zihao Liu, Shan Wang et al. (18 authors)
Asian Journal of Pharmaceutical Sciences
Open Access
Published: Mar 2023
24 citations
24 citations
246 days before retraction
Brazilein inhibits epithelial-mesenchymal transition (EMT) and programmed death ligand 1 (PD-L1) expression in breast cancer cells
Benjawan Wudtiwai, Kanchanok Kodchakorn, Thuzar Hla Shwe et al. (7 authors)
International Immunopharmacology
Published: Mar 2023
10 citations
10 citations
258 days before retraction
Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
Chao Lin, Ning Wang, Chengyan Xu
Frontiers in Immunology
Open Access
Published: Mar 2023
47 citations
47 citations
265 days before retraction
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
Stefaan Van Gool, Jennifer Makalowski, Peter Van de Vliet et al. (7 authors)
Cancers
Open Access
Published: Feb 2023
8 citations
8 citations
289 days before retraction
Retracted: IFN‐<i>γ</i> induces PD‐L1 through p38/JNK/ERK signaling pathways and counteracts the tumor promoting effect mediated by PD‐L1 in Glioblastoma
Computational Intelligence and Neuroscience
Computational Intelligence and Neuroscience
Open Access
Published: Jan 2023
332 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025